» Articles » PMID: 32116112

Oncogenic Hsa_circ_0091581 Promotes the Malignancy of HCC Cell Through Blocking MiR-526b from Degrading C-MYC MRNA

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2020 Mar 3
PMID 32116112
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs (circRNAs) are new types of endogenous non-coding RNAs, which are identified to have critical regulatory roles in cancer biology. In this study, we aimed to find the abnormally expressed circRNAs in hepatocellular carcinoma (HCC) and investigate the function and mechanism of circRNAs in HCC progression. Upregulation of hsa_circ_0091581 was identified by RNA-sequencing and validated by quantitative real-time polymerase chain reaction (qRT-PCR). Hsa_circ_0091581 expression was correlated with tumor size, disease-free survial and overall survival of HCC patients. Functionally, hsa_circ_0091581 could promote the proliferation of HCC cells in vitro. Mechanism research showed that hsa_circ_0091581 promoted cell proliferation via hsa_circ_0091581/miR-526b/c-Myc axis in HCC cells. Also, the expression of hsa_circ_0091581 in HCC could be regulated by c-Myc. These results revealed that hsa_circ_0091581/miR-526b/c-Myc/hsa_circ_0091581 positive feedback loop plays a vital role in HCC progression and hsa_circ_0091581 may be a potential prognostic biomarker and therapeutic target for HCC.

Citing Articles

Circular RNAs in Cell Cycle Regulation of Cancers.

Thamjamrassri P, Ariyachet C Int J Mol Sci. 2024; 25(11).

PMID: 38892280 PMC: 11173060. DOI: 10.3390/ijms25116094.


Overexpression of circZNF720 Inhibits Hepatocellular Carcinoma Progression by Regulating miR-421/MAPK9.

Yang F, Zhuang Z, Liu C, Li F, Zhou J Mol Biotechnol. 2023; 66(5):1165-1173.

PMID: 38159171 DOI: 10.1007/s12033-023-01016-2.


Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy.

Abaza T, Abd El-Aziz M, Daniel K, Karousi P, Papatsirou M, Fahmy S Int J Mol Sci. 2023; 24(22).

PMID: 38003674 PMC: 10671287. DOI: 10.3390/ijms242216484.


The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens.

Tavakoli Pirzaman A, Ebrahimzadeh Pirshahid M, Babajani B, Rahmati A, Niknezhad S, Hosseinzadeh R Technol Cancer Res Treat. 2023; 22:15330338231206003.

PMID: 37849311 PMC: 10586010. DOI: 10.1177/15330338231206003.


Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology.

Rao G, Peng X, Tian Y, Fu X, Zhang Y Front Genet. 2023; 14:1106665.

PMID: 37485335 PMC: 10361733. DOI: 10.3389/fgene.2023.1106665.


References
1.
Li L, Jin R, Zhang X, Lv F, Liu L, Liu D . Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma. Hepatology. 2012; 56(4):1380-90. DOI: 10.1002/hep.25891. View

2.
Boxer L, Dang C . Translocations involving c-myc and c-myc function. Oncogene. 2001; 20(40):5595-610. DOI: 10.1038/sj.onc.1204595. View

3.
Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

4.
Qu S, Liu Z, Yang X, Zhou J, Yu H, Zhang R . The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 2017; 414:301-309. DOI: 10.1016/j.canlet.2017.11.022. View

5.
Zhou F, Shang W, Yu X, Tian J . Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment. Med Res Rev. 2017; 38(2):741-767. DOI: 10.1002/med.21455. View